Patents by Inventor Fabiana Perna

Fabiana Perna has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNOTHERAPEUTIC TARGETS IN MULTIPLE MYELOMA AND METHODS FOR THEIR IDENTIFICATION
    Publication number: 20230137672
    Abstract: Surface proteins predominantly associated with multiple myeloma are identified as potential targets for developing anti-multiple myeloma therapeutics. In accordance with one embodiment antibodies are generated that specifically bind to epitopes of the identified protein that are associated with multiple myeloma cells. These antibodies can then be used to target the delivery of cytotoxic agents to multiple myeloma cells in a patient or used to prepare CAR T-cells for the treatment of multiple myeloma patients.
    Type: Application
    Filed: March 26, 2021
    Publication date: May 4, 2023
    Inventor: Fabiana PERNA
  • CANCER ANTIGEN TARGETS AND USES THEREOF
    Publication number: 20220074945
    Abstract: The presently disclosed subject matter provides methods and compositions for treating myeloid disorders (e.g., acute myeloid leukemia (AML)). It relates to immunoresponsive cells bearing antigen recognizing receptors (e.g., chimeric antigen receptors (CARs)) targeting AML-specific antigens.
    Type: Application
    Filed: November 22, 2021
    Publication date: March 10, 2022
    Applicant: MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: Michel Sadelain, Fabiana Perna
  • Cancer antigen targets and uses thereof
    Patent number: 11193938
    Abstract: The presently disclosed subject matter provides methods and compositions for treating myeloid disorders (e.g., acute myeloid leukemia (AML)). It relates to immunoresponsive cells bearing antigen recognizing receptors (e.g., chimeric antigen receptors (CARs)) targeting AML-specific antigens.
    Type: Grant
    Filed: April 30, 2018
    Date of Patent: December 7, 2021
    Assignee: MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: Michel Sadelain, Fabiana Perna
  • CANCER ANTIGEN TARGETS AND USES THEREOF
    Publication number: 20200182880
    Abstract: The presently disclosed subject matter provides methods and compositions for treating myeloid disorders (e.g., acute myeloid leukemia (AML)). It relates to immunoresponsive cells bearing antigen recognizing receptors (e.g., chimeric antigen receptors (CARs)) targeting AML-specific antigens.
    Type: Application
    Filed: February 19, 2020
    Publication date: June 11, 2020
    Applicant: MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: Michel Sadelain, Fabiana Perna
  • CANCER ANTIGEN TARGETS AND USES THEREOF
    Publication number: 20180348227
    Abstract: The presently disclosed subject matter provides methods and compositions for treating myeloid disorders (e.g., acute myeloid leukemia (AML)). It relates to immunoresponsive cells bearing antigen recognizing receptors (e.g., chimeric antigen receptors (CARs)) targeting AML-specific antigens.
    Type: Application
    Filed: April 30, 2018
    Publication date: December 6, 2018
    Applicant: MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: Michel Sadelain, Fabiana Perna